News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Invitrogen Corporation (IVGN) and the Genome Quebec and Montreal Heart Institute Pharmacogenomics Centre Announce Collaboration to Advance Pharmacogenomics Research



7/1/2008 11:21:10 AM

CARLSBAD, Calif. & MONTREAL--(BUSINESS WIRE)--A scientific collaboration aimed at advancing pharmacogenomics research through the development of novel methodologies and advanced reagents for targeted medical resequencing was announced today by Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, and the Génome Québec and Montreal Heart Institute Pharmacogenomics Centre, a provider of pharmacogenomics research, content, and services.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES